Primary Site >> Liver Cancer
Gene >> RRM2
| 1. | |||||||||||
| Journal: | Cancer Chemother Pharmacol. 2009 Apr;63(5):769-78. | ||||||||||
| Title: | Growth inhibition of hepatocellular carcinoma cells in vitro and in vivo by the 8-methoxy analog of WMC79. | ||||||||||
| Author: | Kosakowska-Cholody, Teresa|Cholody, Wieslaw M|Hariprakasha, Humcha K|Monks, Anne|Kar, Siddhartha|Wang, Meifang|Michejda, Christopher J|Carr, Brian I | ||||||||||
| PMID: | 18641988 | ||||||||||
| 2. | |||||||||||
| Journal: | Clin Cancer Res. 2010 May 1;16(9):2518-28. | ||||||||||
| Title: | Combined functional genome survey of therapeutic targets for hepatocellular carcinoma. | ||||||||||
| Author: | Satow, Reiko|Shitashige, Miki|Kanai, Yae|Takeshita, Fumitaka|Ojima, Hidenori|Jigami, Takafumi|Honda, Kazufumi|Kosuge, Tomoo|Ochiya, Takahiro|Hirohashi, Setsuo|Yamada, Tesshi | ||||||||||
| PMID: | 20388846 | ||||||||||
| 3. | |||||||||||
| Journal: | Cell Physiol Biochem. 2010;26(3):303-10. | ||||||||||
| Title: | RRM2 computational phosphoprotein network construction and analysis between no-tumor hepatitis/cirrhotic liver tissues and human hepatocellular carcinoma (HCC). | ||||||||||
| Author: | Wang, Lin|Huang, Juxiang|Jiang, Minghu | ||||||||||
| PMID: | 20798514 | ||||||||||
| 4. | |||||||||||
| Journal: | Biomaterials. 2013 Dec;34(38):10084-98. | ||||||||||
| Title: | Inhibition of hepatocellular carcinoma growth using immunoliposomes for co-delivery of adriamycin and ribonucleotide reductase M2 siRNA. | ||||||||||
| Author: | Gao, Jie|Chen, Huaiwen|Yu, Yongsheng|Song, Jinjing|Song, Hao|Su, Xiao|Li, Wei|Tong, Xin|Qian, Weizhu|Wang, Hao|Dai, Jianxin|Guo, Yajun | ||||||||||
| PMID: | 24060417 | ||||||||||
| 5. | |||||||||||
| Journal: | Gut Liver. 2014 Nov;8(6):662-8. | ||||||||||
| Title: | High expression of ribonucleotide reductase subunit M2 correlates with poor prognosis of hepatocellular carcinoma. | ||||||||||
| Author: | Lee, Boin|Ha, Sang Yun|Song, Dae Hyun|Lee, Hyun Woo|Cho, Soo Youn|Park, Cheol-Keun | ||||||||||
| PMID: | 25368754 | ||||||||||
| 6. | |||||||||||
| Journal: | Int J Clin Exp Med. 2015 Jul 15;8(7):10388-400. eCollection 2015. | ||||||||||
| Title: | Transarterial chemoembolization (TACE) plus percutaneous ethanol injection (PEI) for the treatment of unresectable hepatocellular carcinoma: a meta-analysis of randomized controlled trials. | ||||||||||
| Author: | Fu, Yang|Zhao, Xu|Yun, Qiang|Zhu, Xueming|Zhu, Yong|Li, Quanwang|Hu, Kaiwen|Wang, Jinwan|Qiao, Zhanbing | ||||||||||
| PMID: | 26379829 | ||||||||||
| 7. | |||||||||||
| Journal: | Anticancer Agents Med Chem. 2016;16(4):440-6. | ||||||||||
| Title: | SCYL1-BP1 affects cell cycle arrest in human hepatocellular carcinoma cells via Cyclin F and RRM2. | ||||||||||
| Author: | Wang, Yang|Zhi, Qiaoming|Ye, Qin|Zhou, Chengyuan|Zhang, Lei|Yan, Wei|Wu, Qun|Zhang, Di|Li, Pu|Huo, Keke | ||||||||||
| PMID: | 25980818 | ||||||||||
| 8. | |||||||||||
| Journal: | Biochem Pharmacol. 2016 Mar 1;103:118-28. | ||||||||||
| Title: | Inhibition of hepatitis B virus replication by targeting ribonucleotide reductase M2 protein. | ||||||||||
| Author: | Liu, Xia|Xu, Zhijian|Hou, Chuanwei|Wang, Meng|Chen, Xinhuan|Lin, Qinghui|Song, Rui|Lou, Meng|Zhu, Lijun|Qiu, Yunqing|Chen, Zhi|Yang, Chunhao|Zhu, Weiliang|Shao, Jimin | ||||||||||
| PMID: | 26774458 | ||||||||||
| 9. | |||||||||||
| Journal: | Medicine (Baltimore). 2017 Jun;96(25):e6938. | ||||||||||
| Title: | Bioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosis. | ||||||||||
| Author: | He, Bosheng|Yin, Jianbing|Gong, Shenchu|Gu, Jinhua|Xiao, Jing|Shi, Weixiang|Ding, Wenbin|He, Ying | ||||||||||
| PMID: | 28640074 | ||||||||||
| 10. | |||||||||||
| Journal: | PeerJ. 2018 Jul 18;6:e5203. | ||||||||||
| Title: | Microarray gene expression profiling in colorectal (HCT116) and hepatocellular (HepG2) carcinoma cell lines treated with Melicope ptelefolia leaf extract reveals transcriptome profiles exhibiting anticancer activity. | ||||||||||
| Author: | Kabir, Mohammad Faujul|Mohd Ali, Johari|Haji Hashim, Onn | ||||||||||
| PMID: | 30042885 | ||||||||||
| 11. | |||||||||||
| Journal: | Int J Mol Med. 2018 Nov;42(5):2393-2402. | ||||||||||
| Title: | An enhanced RRM2 siRNA delivery to rheumatoid arthritis fibroblast-like synoviocytes through a liposomeprotamine-DNA-siRNA complex with cell permeable peptides. | ||||||||||
| Author: | Wang, Xin|Wang, Xueping|Sun, Jin|Fu, Shiou | ||||||||||
| PMID: | 30106091 | ||||||||||